Mitsuyoshi Namba

International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values

Atsunori Kashiwagi, Masato Kasuga, Eiichi Araki et al. · Journal of Diabetes Investigation · 2012 · 889 citations · Full text

International Clinical Harmonization, Metabolic Syndrome, Diabetes Epidemiology +18

Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial

Kohjiro Ueki, Takayoshi Sasako, Yukiko Okazaki et al. · The Lancet Diabetes & Endocrinology · 2017 · 300 citations

Non-pharmacological Intervention, Diabetes Management, Cardiovascular Disease +9

Requirement of Fas for the Development of Autoimmune Diabetes in Nonobese Diabetic Mice

Naoto Itoh, Akihisa Imagawa, Toshiaki Hanafusa et al. · The Journal of Experimental Medicine · 1997 · 238 citations · Full text

Glucagonostatic and Insulinotropic Action of Glucagonlike Peptide I-(7–36)-Amide

Ryoya Komatsu, Tatsuo Matsuyama, Mitsuyoshi Namba et al. · Diabetes · 1989 · 225 citations

International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values

Atsunori Kashiwagi, Masato Kasuga, Eiichi Araki et al. · Diabetology International · 2012 · 214 citations · Full text

Diabetes Management, Health Policy, Glycated Hemoglobin +7